Occurrence of Type 1 Diabetes in Graves' Disease Patients Who Are Positive for Antiglutamic Acid Decarboxylase Antibodies: An 8-Year Followup Study

Table 1

Prevalence of GAD antibodies in Graves’ patients who had not been diagnosed with diabetes at the study start.

	Patient number	GADA(+)	(%)
Graves’ disease	158	10	6.3
untreated	50	2	4.0
treated	108	8	7.4

Difference of prevalence is not statistically significant.